Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Tan (SingaporeS, Singapore), S. Tay (SingaporeS, Singapore), F. Teo (SingaporeS, Singapore), P. Quah (SingaporeS, Singapore), L. Teo (SingaporeS, Singapore), C. Ong (SingaporeS, Singapore), J. Seet (SingaporeS, Singapore), T. Lim (SingaporeS, Singapore). Impact of a Bayesian approach on the diagnosis of Interstitial Lung Diseases. 4693

Member's Comments

No comment yet.

Related content which might interest you: Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used Source: International Congress 2017 – Rare diseases Year: 2017 The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic. Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Gender perspective in Interstitial Lung Diseases (ILD) Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Evaluation of three dyspnea questionnaires in the progression of Interstitial Lung Diseases. Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 The Minapild Study Project: New tools to identify causes and prevent Interstitial Lung Diseases Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Provident Diagnostic Method for Interstitial Lung Disease: Awake Uniportal Videothoracoscopy Source: International Congress 2017 – Thoracic surgery Year: 2017 ATS / ERS: International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias Source: Guideline 2002 Year: 2002 Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 GPs Meet Rare Lung Disorders Task Force factsheet: childhood interstitial lung disease Source: Breathe 2014; 10:173-175 Year: 2014 Case Series of COVID-19 Disease in Pediatric Chronic Lung Diseases Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021 Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience. Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018 Autoantibodies in Interstitial Lung Diseases Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Combined pulmonary fibrosis and emphysema: A report from the Hellenic Interstitial Lung Diseases group Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Effect of Pulmonary Rehabilitation on Functional Exercise Capacity and Hypoxemia in Patients with Interstitial Lung Diseases: a retrospective study Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 Hospitalisation pattern in Interstitial Lung Diseases: a claims data study Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Multicenter Registry of Interstitial Lung Diseases in Brazil Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Utility of Lung Ultrasound in Interstitial Lung Disease - A Paradigm Shift Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 Verification of genetic associations with Scleroderma associated Interstitial Lung Disease Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019